Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011.
paper
Cited
Public
Unavailable
- Authors
- Dickerson, Faith; Stallings, Catherine R; Origoni, Andrea E; Vaughan, Crystal; Khushalani, Sunil; Schroeder, Jennifer; Yolken, Robert H
- Year
- 2013
- Journal
- Psychiatric services (Washington, D.C.)
- PMID
- 23280457
- DOI
- 10.1176/appi.ps.201200143
OBJECTIVE: This study examined the prevalence of cigarette smoking and the quantity of cigarettes consumed by individuals with schizophrenia or bipolar disorder and by those with no psychiatric disorder in the period 1999-2011. METHODS: A total of 991 individuals with schizophrenia, bipolar disorder, or no psychiatric illness provided information about their cigarette smoking at recruitment into a research study for which they were selected without regard to their smoking status. Differences among groups and trends over time among new enrollees were examined with multivariate models. Regression analyses were used to compare smoking between the schizophrenia and bipolar disorder groups. RESULTS: There were marked differences in the prevalence of smoking and in the quantity of cigarettes consumed among the diagnostic groups. Overall, 64% of individuals with schizophrenia, 44% with bipolar disorder, and 19% without psychiatric illness reported that they were current smokers. These group differences remained fairly constant over the observation period, and there were no statistically significant time trends in smoking or cigarette consumption after adjustment for demographic covariates. Within the psychiatric illness groups, smoking and cigarette consumption were significantly associated with less education, a history of substance abuse, longer illness duration, Caucasian race, and schizophrenia diagnosis but not with psychiatric symptom severity. CONCLUSIONS: The prevalence of smoking has remained alarmingly high among individuals with schizophrenia and bipolar disorder in routine psychiatric settings. Concerted efforts are urgently needed to promote smoking cessation in these groups.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Comorbidity of severe psychotic disorders with measures of substance use. | 2014 | 24382686 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Glutathione antioxidant pathways in patients with schizophrenia: relationship with metabolic syndrome. | Mednova IA et al. | β | 2026 | β |
| Alterations in visual function and retinal structure in patients with bipolar disorder. | Comes-CarsΓ M et al. | β | 2025 | β |
| Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study. | Hsu TW et al. | β | 2025 | β |
| Implementation of the healthy heart tool- an algorithm with potential cardiometabolic health benefits in persons with severe mental illness. | Lund-Stenvold EH et al. | β | 2025 | β |
| Painting psychosis: an empirical investigation of the self-portraits of Edvard Munch. | Bettelheim EC et al. | β | 2025 | β |
| Smoking prevalence and correlates among inpatients with schizophrenia or schizoaffective disorder. | Wu C et al. | β | 2025 | β |
| Changes in Cannabis Use Patterns in Psychiatric Populations Pre- and Post-Legalization of Recreational Cannabis Use in Canada: A Repeated Cross-Sectional Survey. | Sorkhou M et al. | β | 2024 | β |
| Contribution of severe mental disorders to fatally harmful effects of physical disorders: national cohort study. | FormΓ‘nek T et al. | β | 2024 | β |
| COVID-19-associated mortality in individuals with serious mental disorders in Sweden during the first two years of the pandemic- a population-based register study. | Gibbs A et al. | β | 2024 | β |
| Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking. | Johnson EC et al. | β | 2024 | β |
| Deaths with COVID-19 and from all-causes following first-ever SARS-CoV-2 infection in individuals with preexisting mental disorders: A national cohort study from Czechia. | FormΓ‘nek T et al. | β | 2024 | β |
| Dying to Quit: Understanding the Burden of Tobacco in Psychiatric Patients-A Clinical Review. | Sprenger S et al. | β | 2024 | β |
| Factors associated with smoking cessation in Chinese psychiatric professionals: A cross-sectional survey. | Chen L et al. | β | 2024 | β |
| Neuroretinal Alterations in Schizophrenia and Bipolar Disorder: An Updated Meta-analysis. | Sheehan N et al. | β | 2024 | β |
| Relationship between mood disorders and substance involvement and the shared genetic liabilities: A population-based study in Taiwan. | Lai RY et al. | β | 2024 | β |
| Smoking behavior is associated with suicidality in individuals with psychosis and bipolar disorder: a systematic quantitative review and meta-analysis. | Pietschnig J et al. | β | 2024 | β |
| Smoking in patients with schizophrenia: Prevalence rate and connections with cognitive functions, psychiatric symptoms, and clinical and demographic characteristics | Wu C et al. | β | 2024 | β |
| Systematic review of tobacco smoking prevalence among young people in treatment for first-episode psychosis. | Thaker P et al. | β | 2024 | β |
| The Impact of Tobacco Use on Weight Loss During a Peer-Led Healthy Lifestyle Intervention for People With Serious Mental Illness Living in Permanent Supportive Housing. | Hawes MR et al. | β | 2024 | β |
| Comparison of Oncogenes, Tumor Suppressors, and MicroRNAs Between Schizophrenia and Glioma: The Balance of Power. | Brown JS | β | 2023 | β |
| Effects of Nicotine Administration in an Enriched Environment on the Behavior of Male MK-801-Exposed Rats. | Salmani N et al. | β | 2023 | β |
| Effects of varenicline on the serum levels of olanzapine in male patients with Schizophrenia: a randomized controlled trial. | Deng M et al. | β | 2023 | β |
| Efficacy and safety of pharmacological intervention for smoking cessation in smokers with diseases: A systematic review and network meta-analysis. | Xing X et al. | β | 2023 | β |
| Optimization of Novel Ξ±7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulators and the Discovery of a Preclinical Development Candidate Molecule (RGH-560). | Ledneczki I et al. | β | 2023 | β |
| Age-specific impacts of nicotine and withdrawal on hippocampal neuregulin signalling. | Keady J et al. | β | 2022 | β |
| An evaluation of the feasibility of implementing a novel tobacco dependence treatment program for high-risk individuals into clinical practice within a community mental health center. | Hogan TH et al. | β | 2022 | β |
| Comparison of Smoking Cessation Program Registration, Participation, Smoking Cessation Medication Utilization, and Abstinence Rates Between Smokers With and Without Schizophrenia, Schizo-affective Disorder, or Bipolar Disorder. | Kertes J et al. | β | 2022 | β |
| Examining pathways between genetic liability for schizophrenia and patterns of tobacco and cannabis use in adolescence. | Jones HJ et al. | β | 2022 | β |
| Implementing Chronic Care Model Treatments for Cigarette Dependence in Community Mental Health Clinics. | Japuntich SJ et al. | β | 2022 | β |
| Mediational pathways of tobacco use among adult daily smokers with psychiatric symptoms in the Population Assessment of Tobacco and Health (PATH) survey. | DeAtley T et al. | β | 2022 | β |
| Mental Health in Lifestyle Medicine: A Call to Action. | Merlo G et al. | β | 2022 | β |
| Noninvasive Brain Stimulation for Nicotine Dependence in Schizophrenia: A Mini Review. | Ward HB et al. | β | 2022 | β |
| Prevalence of cannabis use among tobacco smokers: a systematic review protocol. | Skelton E et al. | β | 2022 | β |
| Prevalence of severe cardiovascular disease in patients with schizophrenia. | Marche JC et al. | β | 2022 | β |
| Sudden cardiac arrest in patients with schizophrenia: A population-based study of resuscitation outcomes and pre-existing cardiovascular disease. | Edwards GG et al. | β | 2022 | β |
| TOBACCO USE DISORDER AND DUAL DISORDERS Joint statement by the Spanish Psychiatry Society and the Spanish Dual Disorders Society. | NΓ©stor S et al. | β | 2022 | β |
| A Single-Arm, Open-Label, Pilot, and Feasibility Study of a High Nicotine Strength E-Cigarette Intervention for Smoking Cessation or Reduction for People With Schizophrenia Spectrum Disorders Who Smoke Cigarettes. | Caponnetto P et al. | β | 2021 | β |
| Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention. | Gomes FV et al. | β | 2021 | β |
| Cigarette Smoking and Schizophrenia: Etiology, Clinical, Pharmacological, and Treatment Implications. | Ding JB et al. | β | 2021 | β |
| Comparison of Perceptions and Smoking Cessation Experiences Between Smokers With and Without Serious Mental Illness in a Large Health Maintenance Organization. | Kertes J et al. | β | 2021 | β |
| COVID-19 vaccination for people with severe mental illness: why, what, and how? | Mazereel V et al. | β | 2021 | β |
| Feasibility and Acceptability of a Collaborative Lung Cancer Screening Educational Intervention Tailored for Individuals With Serious Mental Illness. | Flores EJ et al. | β | 2021 | β |
| Increased Risks of Death and Hospitalization in Influenza/Pneumonia and Sepsis for Individuals Affected by Psychotic Disorders, Bipolar Disorders, and Single Manic Episodes: A Retrospective Cross-Sectional Study. | Nilsson NH et al. | β | 2021 | β |
| Integrated Smoking Cessation for Smokers With Serious Mental Illness: Protocol for a Convergent Mixed Methods Implementation Evaluation Study. | Schnitzer K et al. | β | 2021 | β |
| Morbidity and mortality in schizophrenia with comorbid substance use disorders. | LΓ€hteenvuo M et al. | β | 2021 | β |
| Perceptions of smoking cessation and a novel psychosocial intervention for quitting among individuals with psychosis: A qualitative study. | Moe AM et al. | β | 2021 | β |
| Schizotypy, Lifestyle Behaviors, and Health Indicators in a Young Adult Sample. | Dinzeo TJ et al. | β | 2021 | β |
| Systematic Review of Psychosocial Smoking Cessation Interventions for People with Serious Mental Illness. | Hawes MR et al. | β | 2021 | β |
| The association between smoking behaviour, social cognition and social functioning in patients with a non-affective psychotic disorder: A prospective follow-up study. | Dekker TEG et al. | β | 2021 | β |
| The Differential Impact of Lockdown Measures Upon Migrant and Female Psychiatric Patients - A Cross-Sectional Survey in a Psychiatric Hospital in Berlin, Germany. | Moran JK et al. | β | 2021 | β |
| Treatment of Patients with Mental Illness Amid A Global COVID-19 Pandemic. | Jain A et al. | β | 2021 | β |
| Approved and emerging smoking cessation treatments for people with schizophrenia spectrum disorders: A narrative review. | Caponnetto P et al. | β | 2020 | β |
| Cardiometabolic Risk in First Episode Psychosis Patients. | Smith J et al. | β | 2020 | β |
| Chronic Disease Screening and Prevention Activities in Mental Health Clinics in New York State: Current Practices and Future Opportunities. | Compton MT et al. | β | 2020 | β |
| Death Associated With Coronavirus (COVID-19) Infection in Individuals With Severe Mental Disorders in Sweden During the Early Months of the Outbreak-An Exploratory Cross-Sectional Analysis of a Population-Based Register Study. | Maripuu M et al. | β | 2020 | β |
| Effectiveness of Proactive Tobacco Cessation Treatment Outreach Among Smokers With Serious Mental Illness. | Japuntich SJ et al. | β | 2020 | β |
| Internet gaming as a coping method among schizophrenic patients facing psychological distress. | Chang YH et al. | β | 2020 | β |
| Maternal schizophrenia and adverse birth outcomes: what mediates the risk? | Vigod SN et al. | β | 2020 | β |
| Nicotine Self-administration Is Not Increased in the Methylazoxymethanol Acetate Rodent Model of Schizophrenia. | Weeks JJ et al. | β | 2020 | β |
| One-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia. | Xia L et al. | β | 2020 | β |
| Proactive Tobacco Treatment in a Behavioral Health Home. | Japuntich SJ et al. | β | 2020 | β |
| Schizophrenia and pregnancy: a national register-based follow-up study among Finnish women born between 1965 and 1980. | Simoila L et al. | β | 2020 | β |
| The Effects of Tobacco Smoking, and Prenatal Tobacco Smoke Exposure, on Risk of Schizophrenia: A Systematic Review and Meta-Analysis. | Hunter A et al. | β | 2020 | β |
| The side effect profile of Clozapine in real world data of three large mental health hospitals. | Iqbal E et al. | β | 2020 | β |
| Tobacco smoking, related harm and motivation to quit smoking in people with schizophrenia spectrum disorders. | Caponnetto P et al. | β | 2020 | β |
| Ability of swept source OCT to detect retinal changes in patients with bipolar disorder. | Polo V et al. | β | 2019 | β |
| Association between lower estimated premorbid intelligence quotient and smoking behavior in patients with schizophrenia. | Hidese S et al. | β | 2019 | β |
| Clozapine-Associated Myoclonus and Stuttering Secondary to Smoking Cessation and Drug Interaction: A Case Report. | Chochol MD et al. | β | 2019 | β |
| Cognitive functions in smoking and non-smoking patients with schizophrenia: A systematic review and meta-analysis of comparative studies. | Wang YY et al. | β | 2019 | β |
| HIV, schizophrenia, and all-cause mortality: A population-based cohort study of individuals accessing universal medical care from 1998 to 2012 in British Columbia, Canada. | Closson K et al. | β | 2019 | β |
| Interventions to integrate care for people with serious mental illness and substance use disorders: a systematic scoping review protocol. | Richardson A et al. | β | 2019 | β |
| Lung Cancer Screening Eligibility, Risk Perceptions, and Clinician Delivery of Tobacco Cessation Among Patients With Schizophrenia. | Irwin KE et al. | β | 2019 | β |
| Nicotine consumption during the prodromal phase of schizophrenia - a review of the literature. | Gogos A et al. | β | 2019 | β |
| Nicotine dependence in community-dwelling Chinese patients with schizophrenia. | Li Y et al. | β | 2019 | β |
| Patients With Drug-Naive Bipolar Disorder in Remission After 8 Weeks of Treatment Had Decreased Serum Uric Acid Concentrations. | Chen JX et al. | β | 2019 | β |
| Prevalence and smokers' profile: comparisons between the psychiatric population and the general population. | Oliveira RM et al. | β | 2019 | β |
| Risk of Upper Gastrointestinal Bleeding and Gastroduodenal Ulcers in Persons With Schizophrenia: A Danish Cohort Study. | Cotton CC et al. | β | 2019 | β |
| Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial. | Heffner JL et al. | β | 2019 | β |
| Schizophrenia and Nicotine Dependence: What Psychopharmacological Treatment Options are Available for the Duo Perturbationes? | Theng YM et al. | β | 2019 | β |
| Support for Patients Who Have Difficulty Quitting Smoking: A Review. | Komiyama M et al. | β | 2019 | β |
| Tobacco smoking and nicotine dependence in first episode and established psychosis. | Lally J et al. | β | 2019 | β |
| VISUAL FUNCTION AND RETINAL CHANGES IN PATIENTS WITH BIPOLAR DISORDER. | Garcia-Martin E et al. | β | 2019 | β |
| Visual impairments in tobacco use disorder. | Fernandes TP et al. | β | 2019 | β |
| Cigarette Smoking by Patients With Serious Mental Illness, 1999-2016: An Increasing Disparity. | Dickerson F et al. | β | 2018 | β |
| Initial Cross-Over Test of A Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers With Or Without Schizophrenia. | Perkins KA et al. | β | 2018 | β |
| Mental and Addictive Disorders and Medical Comorbidities. | Walker ER et al. | β | 2018 | β |
| Morbidity burden and community-based palliative care are associated with rates of hospital use by people with schizophrenia in the last year of life: A population-based matched cohort study. | Spilsbury K et al. | β | 2018 | β |
| Nicotine dependence in Croatian male inpatients with schizophrenia. | Ε agud M et al. | β | 2018 | β |
| Obstetric and perinatal health outcomes related to schizophrenia: A national register-based follow-up study among Finnish women born between 1965 and 1980 and their offspring. | Simoila L et al. | β | 2018 | β |
| Prevalence of Comorbid Chronic Obstructive Pulmonary Disease in Individuals Suffering from Schizophrenia and Bipolar Disorder: A Systematic Review. | Zareifopoulos N et al. | β | 2018 | β |
| Psychophysical evaluation of contrast sensitivity using Gabor patches in tobacco addiction. | Fernandes TMP et al. | β | 2018 | β |
| Rate of Tobacco Smoking Among Psychiatric Outpatients Attending a Tertiary Care Hospital in Oman: β¨A Cross-sectional Study. | Al Risi K et al. | β | 2018 | β |
| Tobacco Screening and Counseling in the U.S.: Smokers With Mental Health and Substance Use Problems. | Samples H et al. | β | 2018 | β |
| Tobacco smoking and its association with cognition in first episode psychosis patients. | Hickling LM et al. | β | 2018 | β |
| User-Centered Design of Learn to Quit, a Smoking Cessation Smartphone App for People With Serious Mental Illness. | Vilardaga R et al. | β | 2018 | β |
| Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations. | Cather C et al. | β | 2017 | β |
| A Cross-sectional Study to Estimate Cardiovascular Risk Factors in Patients with Bipolar Disorder. | Damegunta SR et al. | β | 2017 | β |
| Chronic pain management group psychotherapy for psychiatric inpatients: A pilot study. | Osborne PJ et al. | β | 2017 | β |
| Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial. | Brody AL et al. | β | 2017 | β |
| Comparison of Suicide Attempts/Behaviors Following Smoking Cessation Treatments Among Schizophrenic Smokers. | Wu IH et al. | β | 2017 | β |
| Consumer and carer perspectives in the development of a mental health research, treatment and teaching facility: A thematic analysis. | Katsikitis M et al. | β | 2017 | β |
| Cortisol in schizophrenia: No association with tobacco smoking, clinical symptoms or antipsychotic medication. | Nedic Erjavec G et al. | β | 2017 | β |
| Genetically contextual effects of smoking on genome wide DNA methylation. | Dogan MV et al. | β | 2017 | β |
| Genome-wide meta-analysis identifies a novel susceptibility signal at CACNA2D3 for nicotine dependence. | Yin X et al. | β | 2017 | β |
| Improving life expectancy in people with serious mental illness: should we place more emphasis on primary prevention? | Ilyas A et al. | β | 2017 | β |
| Predictors of smoking cessation group treatment engagement among veterans with serious mental illness. | Travaglini LE et al. | β | 2017 | β |
| Predictors of the Perception of Smoking Health Risks in Smokers With or Without Schizophrenia. | Kowalczyk WJ et al. | β | 2017 | β |
| Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy. | Schuster RM et al. | β | 2017 | β |
| Preparing the workforce for integrated healthcare: A systematic review. | Black DR | β | 2017 | β |
| Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. | Correll CU et al. | β | 2017 | β |
| Prevalence of smoking in patients with bipolar disorder, major depressive disorder and schizophrenia and their relationships with quality of life. | Li XH et al. | β | 2017 | β |
| Psychoactive substance use in specialized psychiatric care patients. | Karpov B et al. | β | 2017 | β |
| Six-Month Outcomes for Collaborative Care Management of Depression Among Smoking and Nonsmoking Patients. | Witt DR et al. | β | 2017 | β |
| Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study. | Marcus MM et al. | β | 2016 | β |
| Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with age of smoking initiation in male schizophrenia smokers. | Zhang XY et al. | β | 2016 | β |
| Cancer in patients with schizophrenia: What is the next step? | Chou FH et al. | β | 2016 | β |
| Cardiovascular diseases among patients with schizophrenia. | Azad MC et al. | β | 2016 | β |
| Diabetes and Schizophrenia. | Suvisaari J et al. | β | 2016 | β |
| Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis. | Roberts E et al. | β | 2016 | β |
| Exploring Issues of Comorbid Conditions in People Who Smoke. | Rojewski AM et al. | β | 2016 | β |
| Improvements in Somatic Complaints Among Individuals With Serious Mental Illness Receiving Treatment in a Psychiatric Hospital. | Madan A et al. | β | 2016 | β |
| Lifestyle and Behavioral Interventions to Reduce the Risk of Metabolic Syndrome in Community-Dwelling Adults With Serious Mental Illness: Implications for Nursing Practice. | Richards L et al. | β | 2016 | β |
| Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio. | Allenby CE et al. | β | 2016 | β |
| Serum Cotinine Does Not Predict Neutralizing Antibodies Against Interferon Beta in an Austrian MS Cohort. | Auer M et al. | β | 2016 | β |
| Smoking and Serum Lipid Profiles in Schizophrenia. | An HM et al. | β | 2016 | β |
| Smoking in male patients with schizophrenia in China: A meta-analysis. | Li Y et al. | β | 2016 | β |
| Smoking Topography Characteristics of Very Low Nicotine Content Cigarettes, With and Without Nicotine Replacement, in Smokers With Schizophrenia and Controls. | Tidey JW et al. | β | 2016 | β |
| Strategies to deal with comorbid physical illness in psychosis. | Docherty M et al. | β | 2016 | β |
| The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls. | Dickerson F et al. | β | 2016 | β |
| The use of peer mentors to enhance a smoking cessation intervention for persons with serious mental illnesses. | Dickerson FB et al. | β | 2016 | β |
| Weight gain and 10-year cardiovascular risk with sustained tobacco abstinence in smokers with serious mental illness: a subgroup analysis of a randomized trial. | Thorndike AN et al. | β | 2016 | β |
| A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults. | Jackson JG et al. | β | 2015 | β |
| An overview of diabetes management in schizophrenia patients: office based strategies for primary care practitioners and endocrinologists. | Annamalai A et al. | β | 2015 | β |
| A pilot study of the diabetes prevention program on weight loss for adults at community mental health centers. | Srebnik D et al. | β | 2015 | β |
| Cigarette smoking in obsessive-compulsive disorder and unaffected parents of OCD patients. | Abramovitch A et al. | β | 2015 | β |
| Clinical management of comorbid diabetes and psychotic disorders. | Chwastiak LA et al. | β | 2015 | β |
| Current smoking is associated with worse cognitive and adaptive functioning in serious mental illness. | Depp CA et al. | β | 2015 | β |
| Metagenomic Sequencing Indicates That the Oropharyngeal Phageome of Individuals With Schizophrenia Differs From That of Controls. | Yolken RH et al. | β | 2015 | β |
| Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia. | Egbujo CN et al. | β | 2015 | β |
| Nicotine effects in adolescence and adulthood on cognition and Ξ±βΞ²β-nicotinic receptors in the neonatal ventral hippocampal lesion rat model of schizophrenia. | Berg SA et al. | β | 2015 | β |
| Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. | Vancampfort D et al. | β | 2015 | β |
| Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid Disorders. | Fisher ML et al. | β | 2015 | β |
| Smoking Cessation in Individuals With Serious Mental Illness: A Randomized Controlled Trial of Two Psychosocial Interventions. | Bennett ME et al. | β | 2015 | β |
| Smoking in schizophrenic patients: A critique of the self-medication hypothesis. | Manzella F et al. | β | 2015 | β |
| Smoking Use and Cessation Among People with Serious Mental Illness. | Annamalai A et al. | β | 2015 | β |
| Thirty-Day Hospital Readmission for Medicaid Enrollees with Schizophrenia: The Role of Local Health Care Systems. | Busch AB et al. | β | 2015 | β |
| Translational utility of rodent hippocampal auditory gating in schizophrenia research: a review and evaluation. | Smucny J et al. | β | 2015 | β |
| Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices. | Evins AE et al. | β | 2015 | β |
| [Vigilance level for cardiovascular risk factors in schizophrenic patients]. | Rouillon F et al. | β | 2015 | β |
| Cancer care for individuals with schizophrenia. | Irwin KE et al. | β | 2014 | β |
| Comorbidity of severe psychotic disorders with measures of substance use. | Hartz SM et al. | β | 2014 | β |
| Effect of smoking on the pharmacokinetics of inhaled loxapine. | Takahashi LH et al. | β | 2014 | β |
| Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions. | Ringen PA et al. | β | 2014 | β |
| Modulation of auditory deviance detection by acute nicotine is baseline and deviant dependent in healthy nonsmokers: a mismatch negativity study. | Knott V et al. | β | 2014 | β |
| Prevalence and correlates of cigarette smoking among Chinese schizophrenia inpatients receiving antipsychotic mono-therapy. | Xu YM et al. | β | 2014 | β |
| Smoking and suicidality in patients with a psychotic disorder. | Sankaranarayanan A et al. | β | 2014 | β |
| The interface of physical and mental health. | Doherty AM et al. | β | 2014 | β |
| Tobacco use treatment in primary care patients with psychiatric illness. | Cerimele JM et al. | β | 2014 | β |
| Treating complexity: collaborative care for multiple chronic conditions. | Chwastiak L et al. | β | 2014 | β |
| Combination of Resting State fMRI, DTI, and sMRI Data to Discriminate Schizophrenia by N-way MCCAβ+βjICA. | Sui J et al. | β | 2013 | β |
| Effectiveness of a multi-component Smoking Cessation Support Programme (McSCSP) for patients with severe mental disorders: study design. | Garcia-Portilla MP et al. | β | 2013 | β |
| Nicotinic modulation of intrinsic brain networks in schizophrenia. | Smucny J et al. | β | 2013 | β |
| Osteoporosis associated with antipsychotic treatment in schizophrenia. | Wu H et al. | β | 2013 | β |
| Schizophrenia and visual backward masking: a general deficit of target enhancement. | Herzog MH et al. | β | 2013 | β |
| Sleep quality during euthymia in bipolar disorder: the role of clinical features, personality traits, and stressful life events. | Saunders EF et al. | β | 2013 | β |
| Smoking among individuals with schizophrenia in Korea: gender differences. | Kim SS et al. | β | 2013 | β |
| The effects of prenatal stress on alpha4 beta2 and alpha7 hippocampal nicotinic acetylcholine receptor levels in adult offspring. | Schulz KM et al. | β | 2013 | β |
| The presentation, recognition and management of bipolar depression in primary care. | Cerimele JM et al. | β | 2013 | β |